Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
Status:
Terminated
Trial end date:
2019-10-09
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of naloxegol (Movantik) to a laxative protocol in
critically ill adults requiring scheduled opioid (e.g. fentanyl) therapy. Half of the
participants will receive naloxegol and a laxative protocol and half the participants will
receive a placebo and a laxative protocol.